Educational draft · awaiting clinical reviewUse Rapid for revision, not patient-care decisions. Check current national and local guidance and the BNF or BNFC before acting.
2 min synopsisUK scopeSources checked 27 Aug 2026Clinical review pending
!
Escalate
Treat new or prolonged rest pain with ECG change or troponin rise as possible ACS until excluded. Coronary spasm can cause infarction, syncope and ventricular arrhythmia and may require urgent monitored care.
Synopsis
Recognise angina with non-obstructive coronary arteries, identify vasospastic or microvascular endotypes and use mechanism-directed testing and treatment.
Non-obstructive coronary arteries do not make angina non-cardiac; consider epicardial spasm and coronary microvascular dysfunction.
Vasospastic angina often occurs at rest, particularly at night or early morning, with transient ST change and prompt nitrate response.
Microvascular angina may be exertional or occur at rest and can persist longer than classic obstructive angina.
Key red flags
High-risk spasm
Syncope, ventricular arrhythmia, infarction or prolonged ST elevation during an episode requires urgent monitored specialist management.
Investigation priorities
01
12-lead ECG during symptomsFirst step
Document transient ischaemic change or arrhythmia.
Management branches
Preferred routeAcute rest pain
Current severe or prolonged symptoms
Use the ACS pathway with ECG, serial troponin, monitoring and urgent assessment; give sublingual GTN when safe.
Treat persistent ST elevation, arrhythmia or haemodynamic compromise as an emergency.
Preferred routePersistent ANOCA or INOCA
Angina continues despite non-obstructive CTCA or angiography
Key medicines
Glyceryl trinitrate sublingual spray400–800 micrograms under the tongue at symptom onset; repeat at 5-minute intervals if needed, to a maximum total of 3 sprays, then seek prompt medical help if unresolved.
Amlodipine5 mg orally once daily, increased to 10 mg once daily according to response and tolerance.
National guidance is shown before implementation-dependent detail. Typical adult dose examples remain subject to patient factors, contraindications and the live BNF or specialist protocol. Source check completed 27 Aug 2026; clinical approval remains outstanding.